Skip to content

UK heel fracture trial: surgical treatment versus non-operative care

Improved functional outcome in heel fracture with surgical treatment versus non-operative care: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN37188541
Enrollment
150
Registered
2006-02-22
Start date
2006-06-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calcaneal fracture Musculoskeletal Diseases Calcaneal fracture

Interventions

Intervention: open reduction and internal fixation by extensile lateral approach Control: non-surgical treatment with elevation and ice followed by spintage and early mobilisation

Sponsors

University Hospitals Coventry and Warwickshire NHS Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Closed displaced intra-articular fractures of the calcaneus 2. Aged over 18 years, no upper age limit, either sex

Exclusion criteria

Exclusion criteria: Amended as of 09/02/2009: 1. Calcaneal fracture with severe deformity resulting in fibula impingement 2. Previous calcaneal abnormality (infection, tumour or deformity) 3. Other serious injuries to either lower limb that would interfere with rehabilitation of the index calcaneal fracture 4. Peripheral vascular disease (defined as having been investigated or treated for poor lower limb circulation) 5. Other contra-indication to surgery, defined as: 5.1. Severe cardiac impairment, e.g. heart or valve replacement, arrhythmia, previous myocardial infarction 5.2. Severe respiratory impairment, e.g. chronic obstructive pulmonary disease, asthma that has required hospital admission 5.3. Any other systemic medical condition that would produce a specific contraindication to a general anaesthetic 6. Evidence that the patient would be unable to adhere to trial procedures or complete questionnaires, such as dementia or intravenous drug abuse Initial information at time of registration: 1. Diabetes 2. Peripheral vascular disease, or other local or systemic contra-indication to surgery 3. Injury to the ipsilateral leg 4. Very severe deformity with the lateral wall of the calcaneus impinging upon the fibula

Design outcomes

Primary

MeasureTime frame
The Kerr Calcaneal Fracture Score (a validated, reliable, patient-derived outcome instrument for pain and function following calcaneal fracture, accepted by surgeons working in the area)

Secondary

MeasureTime frame
Amended as of 09/02/2009: Point four has been amended as follows: 4. Gait and foot pressure analysis using F-Scan for gait analysis. This is an in shoe pressure system which also enables objective assessment of various parameters of gait. Initial information at time of registration: 1. Complications, including wound dehiscence, infection, mal-union, non-union and radiographic arthritis 2. General health using the SF-36 questionnaire 3. American Orthopaedic Foot and Ankle Society Hind Foot Score 4. Gait and foot pressure analysis using GAITRite (a simple portable pressure sensitive mat connected to a laptop computer that enables objective assessment of various parameters of gait including walking speed, step length, and dynamic contact pressures) 5. Health status using EQ-5D 6. Resource use will be monitored for the economic analysis. National Health Service (NHS) costs will be collated for each trial arm. Cost-consequences will be monitored via short questionnaires. In addition, average time off work or reduced working hours attributed to the condition in both groups will be recorded.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 7, 2026